Company Name
Zhuhai Rundu Pharmaceutical Co.,Ltd.
Year of Establishment
1997
Enterprise Size
more than 1000
Annual Turnover(USD)
500,000 to 99,999,999
Company Introduction
Zhuhai Rundu Pharmaceutical Co.,Ltd. is approved by USFDA, WHO, NMPA, MFDS, PMDA etc.authorities, specialized in the pharmaceutical APIs and intermediates, takes advantage of the production in SARTAN antihypertensive bulk, with the best quality and the most massive production in the domestic market. Our main products include not only Valsartan,Irbesartan Candesartan Cilexetil,Olmesartan Medoxomil, Sacubitril / Valsartan and their related intermediates, but also Piperaquine Phosphate and Voriconazole etc.
Main Competitive Advantages
Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service,
Website
http://www.rdpharma.cn